These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 12144548

  • 1. Leukotriene receptor antagonists in the treatment of asthma: an update.
    Balzano G, Fuschillo S, Gaudiosi C.
    Allergy; 2002; 57 Suppl 72():16-9. PubMed ID: 12144548
    [Abstract] [Full Text] [Related]

  • 2. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS.
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [Abstract] [Full Text] [Related]

  • 3. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS, Cates CJ, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003137. PubMed ID: 15674901
    [Abstract] [Full Text] [Related]

  • 4. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM, Lasserson TJ, Cates CJ.
    Cochrane Database Syst Rev; 2006 Oct 18; (4):CD003137. PubMed ID: 17054161
    [Abstract] [Full Text] [Related]

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 18; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 6. Leukotriene-receptor antagonists. Role in asthma management.
    D'Urzo AD, Chapman KR.
    Can Fam Physician; 2000 Apr 18; 46():872-9. PubMed ID: 10790819
    [Abstract] [Full Text] [Related]

  • 7. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.
    Pediatrics; 2001 Sep 18; 108(3):E48. PubMed ID: 11533366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L, Diamant Z.
    Monaldi Arch Chest Dis; 2002 Feb 18; 57(1):76-83. PubMed ID: 12174707
    [Abstract] [Full Text] [Related]

  • 11. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D, Salvio F, Hicks G.
    Cochrane Database Syst Rev; 2004 Feb 18; (2):CD002314. PubMed ID: 15106175
    [Abstract] [Full Text] [Related]

  • 12. Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
    Dempsey OJ, Fowler SJ, Wilson A, Kennedy G, Lipworth BJ.
    Chest; 2002 Jul 18; 122(1):151-9. PubMed ID: 12114351
    [Abstract] [Full Text] [Related]

  • 13. Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis.
    Miligkos M, Bannuru RR, Alkofide H, Kher SR, Schmid CH, Balk EM.
    Ann Intern Med; 2015 Nov 17; 163(10):756-67. PubMed ID: 26390230
    [Abstract] [Full Text] [Related]

  • 14. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM, Hicks GC.
    Cochrane Database Syst Rev; 2000 Nov 17; (3):CD002314. PubMed ID: 10908555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z, Dekhuijzen PN.
    Ned Tijdschr Geneeskd; 2003 Aug 30; 147(35):1681-5. PubMed ID: 14513539
    [Abstract] [Full Text] [Related]

  • 19. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B, Markham A.
    Drugs; 2000 Apr 30; 59(4):891-928. PubMed ID: 10804041
    [Abstract] [Full Text] [Related]

  • 20. The role of LTRAs in the management of persistent asthma.
    Stoloff SW.
    Postgrad Med; 2000 Sep 15; 108(4 Suppl):22-31. PubMed ID: 19681236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.